Subscribe to RSS
DOI: 10.1055/s-0040-1713638
Liver Lymphatic Imaging and Interventions: Resurrection of the Forgotten Knowledge
Publication History
Publication Date:
31 July 2020 (online)
Abstract
Lymphatic imaging and interventions are gaining wider acceptance as the treatment of various lymphatic diseases. Meanwhile, the liver lymphatic system remains relatively unknown despite its physiological importance. Liver lymph has been at the center of the lymphatic research since the 19th century; however, the acquired knowledge has not been used in clinical research and treatment due to the lack of robust imaging methods. Recently introduced liver lymphangiography and interstitial embolization allow for the diagnosis and treatment of several diseases associated with the lymphatic system of the congested liver, providing additional treatment options for conditions that were considered incurable until now.
-
References
- 1 Frank BW, Kern Jr F. Intestinal and liver lymph and lymphatics. Gastroenterology 1968; 55 (03) 408-422
- 2 Starling EH. The influence of mechanical factors on lymph production. J Physiol 1894; 16 (3-4): 224-267
- 3 Dumont AE, Witte MH. Significance of excess lymph in the thoracic duct in patients with hepatic cirrhosis. Am J Surg 1966; 112 (03) 401-406
- 4 Witte MH, Dumont AE, Clauss RH, Rader B, Levine N, Breed ES. Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation 1969; 39 (06) 723-733
- 5 Itkin M, Nadolski GJ. Modern techniques of lymphangiography and interventions: current status and future development. Cardiovasc Intervent Radiol 2018; 41 (03) 366-376
- 6 Trutmann M, Sasse D. The lymphatics of the liver. Anat Embryol (Berl) 1994; 190 (03) 201-209
- 7 Levick JR. Revision of the Starling principle: new views of tissue fluid balance. J Physiol 2004; 557 (Pt 3): 704
- 8 Dive CC, Nadalini AC, Heremans JF. Origin and composition of hepatic lymph proteins in the dog. Lymphology 1971; 4 (04) 133-139
- 9 Laine GA, Hall JT, Laine SH, Granger J. Transsinusoidal fluid dynamics in canine liver during venous hypertension. Circ Res 1979; 45 (03) 317-323
- 10 Brauer RW, Holloway RJ, Leong GF. Changes in liver function and structure due to experimental passive congestion under controlled hepatic vein pressures. Am J Physiol 1959; 197: 681-692
- 11 Hyatt RE, Lawrence GH, Smith JR, Sterile OF, Cole WR. Observations on the origin of ascites from experimental hepatic congestion. J Lab Clin Med 1955; 45 (02) 274-280
- 12 Moreno AH, Ruzicka FF, Rousselot LM. , et al. Functional hepatography. Radiology 1963; 81 (01) 65-79
- 13 Goldberg HI, Dodds WJ, Lawson TL, Stewart ET, Moss AA. Hepatic lymphatics demonstrated by percutaneous transhepatic cholangiography. Am J Roentgenol Radium Ther Nucl Med 1975; 123 (02) 415-419
- 14 Cope C. Usefulness of a percutaneous transhepatic coaxial micropuncture needle technique in patients with nondilated peripheral intrahepatic ducts. AJR Am J Roentgenol 2003; 181 (04) 1017-1020
- 15 Sezai S, Sakurabayashi S, Yamamoto Y, Hirano M, Kamisaka K, Oka H. Percutaneous transhepatic lymphography (PTL) for visualizing metastasized lesions from hepatocellular carcinoma. Int Hepatol Commun 1994; 2 (01) 1-5
- 16 Teramoto K, Kawamura T, Okamoto H. , et al. Percutaneous transhepatic lymphography method to image and treat intra-abdominal lymph node metastasis in patients with unresectable hepatobiliary pancreatic cancer. Surgery 2002; 131 (05) 529-533
- 17 Guez D, Nadolski GJ, Pukenas BA, Itkin M. Transhepatic lymphatic embolization of intractable hepatic lymphorrhea. J Vasc Interv Radiol 2014; 25 (01) 149-150
- 18 Witte MH, Witte CL, Dumont AE. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology 1971; 61 (05) 742-750
- 19 Dumont AE, Witte CL, Witte MH. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis. Lymphology 1975; 8 (04) 111-113
- 20 Tanaka K, Ohmori Y, Mohri Y. , et al. Successful treatment of refractory hepatic lymphorrhea after gastrectomy for early gastric cancer, using surgical ligation and subsequent OK-432 (Picibanil) sclerotherapy. Gastric Cancer 2004; 7 (02) 117-121
- 21 Matsumoto S, Mori H, Tada I. Successful demonstration of post-operative lymphatic fistula by percutaneous transhepatic lymphography. Clin Radiol 2000; 55 (06) 485-486
- 22 Landzberg BR, Pochapin MBM. Protein-losing enteropathy and gastropathy. Curr Treat Options Gastroenterol 2001; 4 (01) 39-49
- 23 Itkin M, Piccoli DA, Nadolski G. , et al. Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol 2017; 69 (24) 2929-2937
- 24 Lee H, Kim SJ, Hur S. , et al. the feasibility of mesenteric intranodal lymphangiography: its clinical application for refractory postoperative chylous ascites. J Vasc Interv Radiol 2018; 29 (09) 1290-1292
- 25 Itkin M. Lymphatic intervention techniques: look beyond thoracic duct embolization. J Vasc Interv Radiol 2016; 27 (08) 1187-1188
- 26 Maleux G, Storme E, Cools B. , et al. Percutaneous embolization of lymphatic fistulae as treatment for protein-losing enteropathy and plastic bronchitis in patients with failing Fontan circulation. Catheter Cardiovasc Interv 2019; 94 (07) 996-1002